Business

Live Q&A: What’s the latest on the Covid vaccines?

The UK is on track for its mid-February target to vaccinate the 15m most vulnerable Britons but new variants of coronavirus are causing increasing concern.

The latest research suggests that the Oxford/AstraZeneca vaccine may not stop transmission of the variant first detected in South Africa but what does this mean for people who have already been vaccinated? How effective are the vaccines against Covid-19, and in particular, how effective are they against the new variants?

Clive Cookson, the FT’s science editor in London and Hannah Kuchler, our pharma and biotech reporter based in New York, will answer your questions about vaccine rollouts across the world and emerging variants of the virus throughout the day on Friday February 12.

Post your queries in the comments below and our reporters will drop in regularly to answer them.


Source link

Related Articles

Back to top button